(Q34621423)

English

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Ching-Sheng Hsu

1

1 reference

Europe PubMed Central

3 August 2017

Shih-Jer Hsu

2

1 reference

Europe PubMed Central

3 August 2017

Hung-Chia Chen

3

1 reference

Europe PubMed Central

3 August 2017

Tai-Chung Tseng

4

1 reference

Europe PubMed Central

3 August 2017

Chen-Hua Liu

5

1 reference

Europe PubMed Central

3 August 2017

Wei-Fang Niu

6

1 reference

Europe PubMed Central

3 August 2017

Jenher Jeng

7

1 reference

Europe PubMed Central

3 August 2017

Chun-Jen Liu

8

1 reference

Europe PubMed Central

3 August 2017

Ming-Yang Lai

9

1 reference

Europe PubMed Central

3 August 2017

Pei-Jer Chen

10

1 reference

Europe PubMed Central

3 August 2017

Jia-Horng Kao

11

1 reference

Europe PubMed Central

3 August 2017

Ding-Shinn Chen

12

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

14 February 2011

1 reference

Europe PubMed Central

3 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

3 August 2017

108

1 reference

Europe PubMed Central

3 August 2017

9

1 reference

Europe PubMed Central

3 August 2017

3719-3724

1 reference

Europe PubMed Central

3 August 2017

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Estimation of dynamical model parameters taking into account undetectable marker values

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

IL-28, IL-29 and their class II cytokine receptor IL-28R

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Side effects of therapy of hepatitis C and their management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Transmission of hepatitis C virus in Asia: past and present perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Factors predictive of a beneficial response to therapy of hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: correlation with genotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

Hepatitis C virus infection in Taiwan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

7 July 2018

HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Predictors of response of US veterans to treatment for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Viral kinetics of hepatitis C: new insights and remaining limitations

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Interferon-alfa, interferon-lambda and hepatitis C.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Antiviral action of ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1100349108

21 January 2018

Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

26 October 2018

Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3048137

9 December 2018

Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan

1 reference

https://pubmed.ncbi.nlm.nih.gov/21321200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.1100349108

1 reference

Europe PubMed Central

3 August 2017

2011PNAS..108.3719H

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34621423&oldid=1768991167"